Psychiatry Research: Neuroimaging
Volume 146, Issue 2 , Pages 149-155, 31 March 2006

Antidepressant efficacy of olanzapine as monotherapy in major depressive disorder, without psychosis: A pilot study☆

  • Jose Mathews

      Affiliations

    • Department of Psychiatry, Washington University School of Medicine, Box 8134, 660 S. Euclid, St. Louis, MO 63110, USA
    • ,
  • Keith S. Garcia

      Affiliations

    • Department of Psychiatry, Washington University School of Medicine, Box 8134, 660 S. Euclid, St. Louis, MO 63110, USA
    • ,
  • Mark A. Mintun

      Affiliations

    • Department of Psychiatry, Washington University School of Medicine, Box 8134, 660 S. Euclid, St. Louis, MO 63110, USA
    • Department of Radiology, Washington University School of Medicine, St. Louis, MO, USA
    • ,
  • Yvette I. Sheline

      Affiliations

    • Department of Psychiatry, Washington University School of Medicine, Box 8134, 660 S. Euclid, St. Louis, MO 63110, USA
    • Department of Radiology, Washington University School of Medicine, St. Louis, MO, USA
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, Washington University School of Medicine, Box 8134, 660 S. Euclid, St. Louis, MO 63110, USA. Tel.: +1 314 362 8422; fax: +1 314 362 7599.

Received 12 January 2005; received in revised form 19 July 2005; accepted 7 August 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Disclosure: Dr. Mathews is on the speaker's bureau of Janssen and Bristol-Myers Squibb. Dr. Garcia is on the speaker's bureau of Pfizer and GlaxoSmithKline. Dr. Sheline is on the scientific advisory board of Bristol-Myers Squibb. Dr. Mintun has no conflict of interest disclosure.

PII: S0925-4927(05)00198-8

doi:10.1016/j.pscychresns.2005.08.003

Psychiatry Research: Neuroimaging
Volume 146, Issue 2 , Pages 149-155, 31 March 2006

Article Tools

* Image Usage & Resolution